Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

JAM-A helps hair regrowth in alopecia areata by protecting VCAN in skin cells.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

A new microneedle patch made from hair proteins helps regrow hair faster and better than current treatments.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Rumex japonicus Houtt. may be an effective treatment for atopic dermatitis by reducing inflammation.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Proper control of β-catenin activity is crucial for development and preventing diseases like cancer.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Iron deficiency might contribute to hair loss in women.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

Skin issues can indicate immune system problems.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

Activating Nrf2 in skin cells speeds up wound healing by increasing the growth of certain stem cells.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

Blood-derived CD34+ cells speed up healing, reduce scarring, and regrow hair in skin wounds.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.